SOFTWARE EFF SLTNS CORP - SFWJ STOCK NEWS

MedCana (OTC PINK:SFWJ), a global infrastructure holding company in the pharmaceutical-grade cannabis industry, has announced multiple acquisitions and associated cannabis licenses. The company has acquired a total of 23 licenses, including 7 CBD licenses, 7 THC licenses, 7 licenses for fabrication of cannabis-containing products, and 2 genetics licenses. These acquisitions will add $1.6 million to MedCana's total assets for the 3rd Quarter.

The acquisitions include 100% ownership of several companies: Cannabicolombia group s.a.s., Cannehealth Business s.a.s., Organic Leaves S.A.S., Remedium S.A.S, Royal Cannabis S.A.S, Vital Cannabis S.A.S, and Elemental Genetics S.A.S. Additionally, MedCana has acquired a controlling stake in Eko2o Environmental Solutions S.A.S., a company focused on developing infrastructure for agriculture in Colombia and South America.

MedCana (OTC: SFWJ), a holding company specializing in agricultural technology and the cannabis industry, is exploring opportunities to enter the Australian pharmaceutical cannabis market. The Australian legal cannabis market is projected to reach USD 540.6 million by 2030, with a CAGR of 27.8% from 2024 to 2030.

MedCana aims to establish a presence as both an exporter and licensed producer in Australia. The company's CEO, Gabriel Diaz, highlighted the growing demand for high-quality pharmaceutical cannabis as a perfect opportunity for rapid expansion. MedCana is committed to meeting Australia's rigorous pharmaceutical standards by ensuring all its subsidiaries follow Good Agricultural and Collection Practices (GACP) certification processes.

The expansion into Australia aligns with the country's increasing patient demand, favorable regulatory changes, and expanding access to medicinal cannabis treatments.

SFWJ, operating as MedCana, a cannabis and agricultural technology holding company, has announced the elimination of all Convertible Debt from its Balance sheet by the end of the 3rd Quarter. The company is set to remove $450,000 of convertible debt, with debtholders agreeing to swap their debt for Preferred shares carrying the same rights and interest rate. This move aims to boost investor confidence and prepare the company for its next growth phase.

As part of the agreement, the new preferred shareholders have committed to a 6-month lock-up period. MedCana's CEO, Gabriel Diaz, emphasized the company's focus on revenue growth and enhancing shareholder value, assuring investors that they need not worry about debt conversion impacting their share value.

SFWJ, operating as MedCana, has announced a strategic partnership with a local Colombian company to start exporting CBD buds to Switzerland within six months. This partnership is a significant step in MedCana's European market expansion and highlights its commitment to delivering high-quality CBD products. MedCana CEO Gabriel Diaz emphasized the importance of this collaboration in strengthening the supply chain and penetrating the Swiss market, a vital area for growth. The Colombian partner's expertise in cultivation and processing will be instrumental in meeting stringent Swiss quality standards, aligning with MedCana's goals of sustainable agricultural practices and international market growth.

SFWJ, operating as MedCana, has announced significant progress in its operations. The company is expanding its production area by 2 hectares to meet increasing market demands. In collaboration with its subsidiary Eko2o S.A.S, MedCana has achieved a 35% reduction in construction costs for greenhouses and irrigation systems. CEO Jose Gabriel Diaz emphasized the importance of this expansion, highlighting the company's commitment to operational efficiency, sustainable practices, and stakeholder value. This move underscores MedCana's dedication to excellence and innovation in the cannabis and agricultural technology sectors.

SFWJ, known as MedCana, reacts to the US DEA's decision to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act, marking a significant shift in drug policy. This move opens up opportunities for research, innovation, and accessibility in the cannabis industry.

Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers. The company announces continued growth and expansion as a key infrastructure supplier for Colombia's largest flower producers, with an enhanced collaboration with Danziger International. CEO Juan Ricardo Velez leads the company's reputation for top-tier solutions in agricultural infrastructure. The partnership with Danziger International signifies Eko2o's strategy to increase its global footprint and leverage its expertise in supporting the flower industry. Eko2o's commitment to excellence and innovation attracts major industry players, contributing to Colombia's reputation as a leader in floriculture and agricultural technology.

SFWJ, known as MedCana, a key player in cannabis and agricultural tech, reports significant progress in expanding its portfolio. Subsidiaries are finalizing deals for exports to Europe and Australia, while Eko2o S.A.S. is growing in the agricultural sector. MedCana's cannabis production venture is nearing completion, aiming to meet strict market standards. Eko2o S.A.S. is advancing in distributing tech to major producers. CEO Jose Gabriel Diaz is optimistic about the company's future.

Eko2o S.A.S., a subsidiary of SFWJ, announces plans to expand operations into Costa Rica and Central America to promote sustainable agriculture. The move is driven by the region's environmental policies and demand for innovative farming solutions.